Biogened Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Biogened şirketinin toplam hissedar öz sermayesi PLN39.3M ve toplam borcu PLN23.3M olup, bu da borç-öz sermaye oranını 59.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla PLN87.0M ve PLN47.7M dir. Biogened 'in FAVÖK'ü PLN8.4M faiz karşılama oranı 3.7 dur. Şirketin PLN6.2M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

59.2%

Borç/özkaynak oranı

zł23.29m

Borç

Faiz karşılama oranı3.7x
Nakitzł6.16m
Eşitlikzł39.32m
Toplam yükümlülüklerzł47.66m
Toplam varlıklarzł86.97m

Son finansal sağlık güncellemeleri

Recent updates

Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

Nov 06
Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BGD 'nin kısa vadeli varlıkları ( PLN52.7M ) kısa vadeli yükümlülüklerini ( PLN23.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: BGD şirketinin kısa vadeli varlıkları ( PLN52.7M ) uzun vadeli yükümlülüklerini ( PLN24.2M ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BGD 'nin net borç/öz sermaye oranı ( 43.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: BGD şirketinin borç/öz sermaye oranı son 5 yılda 40.6% seviyesinden 59.2% seviyesine yükseldi.

Borç Kapsamı: BGD 'nin borcu işletme nakit akışı ( 20.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: BGD 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.7 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin